{"id":"W4205561311","doi":"10.1200/jco.21.02647","title":"Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; McMaster University; London Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Adjuvant; Denosumab; Bisphosphonate; Breast cancer; Adjuvant therapy; Guideline; Exemestane; Zoledronic acid","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002164322,0.00012417,0.001363062,0.0001380631,0.00005528377,0.000003836149,0.00008411675,0.0001532761,0.0005116262],"category_scores_gemma":[0.0004834171,0.00009199726,0.0002033617,0.0001667097,0.0001197786,0.00008664795,0.0001063551,0.0008260401,0.000002866687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002318121,"about_ca_system_score_gemma":0.001233881,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002651526,"about_ca_topic_score_gemma":0.0003676127,"domain_scores_codex":[0.9961103,0.0003352719,0.002769757,0.0001821497,0.0003498491,0.000252678],"domain_scores_gemma":[0.9970171,0.0006138682,0.001673441,0.0001441957,0.0001945938,0.000356792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006988368,0.001914636,0.8283237,0.0000393976,0.0002281898,0.000978649,0.00007091551,0.0001051928,0.00003770868,0.00003495303,0.007402681,0.1538756],"study_design_scores_gemma":[0.0118623,0.003107188,0.7166999,0.0001130075,0.0002378739,0.001077206,0.00007338457,0.0005312734,0.00002338638,0.0001249813,0.2660717,0.0000777511],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9758181,0.002815928,0.000004814702,0.02020264,0.0007556778,0.0001998925,0.00008943194,0.000004644084,0.0001088919],"genre_scores_gemma":[0.9803829,0.004001503,0.002170478,0.0130902,0.0001361944,0.000009838996,0.000005014349,0.00002115766,0.0001827232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.258669,"threshold_uncertainty_score":0.5601949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2150645759624845,"score_gpt":0.5088892296439328,"score_spread":0.2938246536814483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}